Title
Category
Credits
Event date
Cost
  • Alzheimer Disease
  • Antipsychotics
  • Dementia
  • Geriatric Psychiatry
  • Neurology
  • Parkinson Disease
  • Psychotic Disorders
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Antipsychotics can be used in the short-term to manage dementia-related psychosis, but serious adverse effects can outweigh benefits. Novel antipsychotics or other agents may offer superior efficacy and safety. Explore the evidence in this CME activity.
  • Delivery of Care
  • Diagnostic Tools
  • Geriatric Psychiatry
  • Neurology
  • Psychotic Disorders
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
What diagnostic criteria and assessment tools would you use for dementia-related psychosis? What strategies may help when discussing psychosis with patients’ family members? Dr Ballard considers these topics in this brief CME activity.
  • Delivery of Care
  • Movement Disorders
  • Neurology
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Measurement-based care has been found to be effective in patients with psychiatric conditions. Learn how to employ MBC for patients with tardive dyskinesia.
  • Antipsychotics
  • Movement Disorders
  • Neurology
  • Patient/Physician Communication
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Do you know how to talk with your patients about the risk for tardive dyskinesia? Follow along as Dr Nierenberg offers tips for clear communication.
  • Diagnostic Tools
  • Movement Disorders
  • Neurology
  • Parkinson Disease
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
What are the cardinal features of Parkinson disease? What other motor and nonmotor symptoms do patients experience? Review diagnosis and assessment tools.
  • Movement Disorders
  • Neurology
  • Parkinson Disease
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Which medications can improve the motor and nonmotor symptoms of Parkinson disease? Dr Isaacson offers strategies to address multiple challenges.
  • Antipsychotics
  • Functional Impairment
  • Movement Disorders
  • Neurology
  • Side Effects
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Two medications are FDA-approved to treat tardive dyskinesia, and new long-term evidence has been reported. Learn more from Dr. Joseph McEvoy.
  • Movement Disorders
  • Neurology
  • Parkinson Disease
  • Side Effects
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
After several years, patients with Parkinson disease often experience OFF episodes, or periods each day when medication efficacy “wears off.” How can you increase their ON time? In this CME activity, follow along as 2 experts review evidence on treatment.
  • Diagnostic Tools
  • Movement Disorders
  • Neurology
  • Parkinson Disease
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
In this CME activity, listen to a panel of MDD experts discuss best practices and novel antidepressants at the 2019 ASCP Annual Meeting.
  • Alzheimer Disease
  • Dementia
  • Neurology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Disclosing a diagnosis of dementia can be one of the most challenging aspects of care for clinicians. Here, learn strategies for disclosing the diagnosis.

Pages